NCT04635956 2020-11-19
Camrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine Carcinomas
Peking Union Medical College Hospital
Phase 2 Unknown
Peking Union Medical College Hospital
Women's Hospital School Of Medicine Zhejiang University